After three months of recovery, financial and volume indicators were off in August, according to Kaufman Hall's monthly report.
Hospital finances and volume took a step back in August after recovering some from the dire months of March and April, according to Kaufman Hall’s most recent hospital report.
The "National Hospital Flash Report," which is based on a sample of 800 hospitals around the country shows, showed declines median operating margins, adjusted discharges and emergency department visits compared with August of last year. Kaufman Hall puts out a report for every month, and the reports have provided some measurements of how hospitals are faring financially during COVID pandemic.
The financial numbers in the September report brighten if funds from the Coronavirus Aid, Relief and Economic Security (CARES) Act are added in, but they are still down relative to last year.
“August was a challenging month for hospitals nationwide, as margins fell across the board. The declines follow three months of moderate gains after devastating losses in the early months of the COVID-19 pandemic,” says the report.
Related: Hospital Finances, Patient Volume Numbers on the Mend, Kaufman Hall Report Shows
HMedian operating margins for the hospitals were 18% lower in August of this year than in August 2019 if the CARES Act money is not included. With the CARES Act, the relative difference narrows to 3%.
The Kaufman Hall numbers show fairly increases in per-patient expenses; for example, the total expense per adjusted discharge was 15% higher in August than in August 2019 and the labor expense per adjusted discharge was 14% higher in August than in August 2019.
Hospitals are seeing a particular larger decline in emergency department visits, according to Kaufman Hall. Visits in August were down 16% compared with August 2019.
Here are some of the volume measures in the report and the relative difference between August of this year and August 2019:
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Trump’s Most Favored Nation Drug Pricing is Back
Published: May 12th 2025 | Updated: May 12th 2025In a press conference, President Donald J. Trump announced that he would sign an executive order that ties drug pricing to prices in other developed countries. He also vowed to cut out the “middlemen” to bring the new prices to American citizens.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Survey Reveals Cancer Doctors Struggle to Keep Up as Treatments Advance Quickly
May 11th 2025A new survey by Johnson & Johnson revealed that oncologists are overwhelmed by the rapid pace of innovation in cancer care, with many calling for better tools, education and collaboration to help integrate new treatments and technologies into everyday practice.
Read More